JAN 18, 2022 8:00 AM PST

Omicron Can't Dodge T Cells

WRITTEN BY: Tara Fernandes

The Omicron variant was first reported in November 2021. More recently, a surge of infections worldwide has led to widespread concern around how easily the variant spreads and how it can evade vaccines, immune defenses, and antibody-based COVID treatments.

Omicron’s ability to sidestep pandemic countermeasures results from its many mutations. Scientists have identified over 30 mutations in the region encoding the spike protein of SARS-CoV-2, which could explain why the efficacy of antibodies targeting earlier variants has begun to wane.

Now, researchers are interested in understanding other immune system elements that are impacted by Omicron infections. Interestingly, they’re finding that while antibodies may be losing their potency, T cell responses have remained effective against Omicron.

T cell antiviral responses have been somewhat overlooked over the course of the pandemic, but they can limit the risk of COVID symptoms escalating. They can recruit other immune cells and kill cells that have been infected by viruses. Interestingly, T cell responses stay elevated long after antibody levels have naturally tapered off. Moreover, T cells recognize larger target areas on the spike protein, meaning that they can still evoke a robust response even in the presence of mutations.

Several studies have released findings supporting the hypothesis that T cells can still recognize and neutralize Omicron. Data from lab-based assays and computational analyses found that most known T cell recognition sites on the spike protein have remained unchanged in Omicron.

In addition, scientists analyzed T cells from vaccinated individuals, and those that have recovered from COVID can produce strong responses to Omicron.

With more variants of SARS-CoV-2 likely to emerge in time, researchers are taking a closer look at how they can harness T cell activity to prevent the onset of severe symptoms.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 06, 2022
Technology
Researchers use CRISPR Technology to Study How Immune Cells Work
FEB 06, 2022
Researchers use CRISPR Technology to Study How Immune Cells Work
The immune system is one of the most complex aspects of human biology. In addition to protecting our body from bacterial ...
MAR 02, 2022
Immunology
Bacteria in the Lungs Can Impact Immune Cells in the Brain
MAR 02, 2022
Bacteria in the Lungs Can Impact Immune Cells in the Brain
Research has revealed that nearly the entire human body has been colonized by microbes. While studies have shown just ho ...
MAR 07, 2022
Neuroscience
Drinking Milk Aggravates Multiple Sclerosis
MAR 07, 2022
Drinking Milk Aggravates Multiple Sclerosis
A protein found in cow’s milk can trigger inflammation in the surrounding areas of neurons in mice, and may have i ...
MAR 30, 2022
Immunology
Killifish Research Model Shows Antibody Diversity Declines with Age
MAR 30, 2022
Killifish Research Model Shows Antibody Diversity Declines with Age
Shown in in this image (courtesy of Max Planck Institute for Biology of Ageing/CC BY-ND) the African killifish can be us ...
APR 03, 2022
Health & Medicine
Deltacron: How Dangerous Is It?
APR 03, 2022
Deltacron: How Dangerous Is It?
It turns out you can have Delta and Omicron at the same time, and it can lead to the recombinant variant deltacron. Firs ...
APR 24, 2022
Immunology
COVID-19 Vaccine is Safe, Effective for Kids & Teens
APR 24, 2022
COVID-19 Vaccine is Safe, Effective for Kids & Teens
A variety of studies by different reseaech groups have now confirmed that the Pfizer-BioNTech mRNA COVID-19 vaccine is s ...
Loading Comments...